Network of proteins modulated by arsenicals and implicated in kidney, bladder and prostate cancer

Aim of our study was to select by network analysis the genes/proteins/miRNAs implicated in kidney, bladder and prostate cancer development upon arsenical exposure. In this way, it has been to highlight a panel of potential molecules related to the molecular mechanisms of arsenical-induced cancerogenesis and suggest their utility as biomarkers or therapeutic targets. This network contains information about proteins modulated by arsenicals in kidney, bladder and prostate cancers.